Records containing: Neuroblastoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-04-06Pilot Study to Determine the Utility of [18F] 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography in Monitoring Patient Response to Chemotherapy in Neuroblastoma
-
CLINICAL_TRIALS study record update · 2017-03-16A Phase 2a Study of Ultratrace™ Iobenguane I 131 in Patients With Relapsed/Refractory High-Risk Neuroblastoma
-
CLINICAL_TRIALS study record update · 2017-03-13Primary Surgical Therapy for Biologically Defined Low-Risk Neuroblastoma: A Pediatric Oncology Group/Children's Cancer Group Intergroup Study
-
CLINICAL_TRIALS study record update · 2017-03-03A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2017-03-01Tumor Detection Using Iodine-131-Labeled Monoclonal Antibody 8H9
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-02-08The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
-
CLINICAL_TRIALS study record update · 2017-02-06Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-risk Neuroblastoma
-
CLINICAL_TRIALS study record update · 2017-02-03Probiotic Enteric Regimen For Easing Complications of Transplant : A Pilot Study (PERFECT Trial)
-
CLINICAL_TRIALS study record update · 2016-12-23A Multi-center Phase I Trial of Temsirolimus in Combination With Valproic Acid in Children and Adolescents With Multiply Relapsed Pediatric Solid Tumors
-
CLINICAL_TRIALS study record update · 2016-10-28A Randomized, Phase I/II Trial of Irinotecan and Temozolomide Compared to Irinotecan and Temozolomide in Combination With TPI 287 in Patients With Primary Refractory or Early Relapsed Neuroblastoma
-
CLINICAL_TRIALS study record update · 2016-10-28A Phase I/II Trial of TPI-287 in Patients With Refractory or Recurrent Neuroblastoma and Medulloblastoma
-
CLINICAL_TRIALS study record update · 2016-10-28A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma
-
CLINICAL_TRIALS study record update · 2016-10-19Allogeneic Hematopoietic Stem Cell Transplantation With Reduced-intensity Conditioning in Children With Neuroblastoma Who Have Failed a Prior Autologous Transplantation
-
CLINICAL_TRIALS study record update · 2016-08-24I-Metaiodobenzylguanidine (MIBG) With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma
-
CLINICAL_TRIALS study record update · 2016-08-08Phase II Study of the Association of Iodobenzylguanidine Meta-I131 (I131 MIBG) and Topotecan in the Treatment of Refractory or Relapsed Metastatic Neuroblastoma
-
CLINICAL_TRIALS study record update · 2016-08-03Phase I Study of Malignancies That Express NY-ESO-1 With T Cell Receptor-transduced T Cells Targeting NY-ESO-1
-
CLINICAL_TRIALS study record update · 2016-07-28A Feasibility Trial Using Molecular-Guided Therapy for the Treatment of Patients With Refractory or Recurrent Neuroblastoma
-
CLINICAL_TRIALS study record update · 2016-07-11Investigation of DICER1 in Cystic Nephroma and Cystic Partially Differentiated Nephroblastoma
-
CLINICAL_TRIALS study record update · 2016-07-11Proposed Studies on the Role of Growth Factor Receptor Trafficking in Neuroblastoma Pathogenesis
-
CLINICAL_TRIALS study record update · 2016-06-24A Pilot Study of Sequential Autologous Stem Cell Transplantation and Immunotherapy With Reduced Intensity Allogeneic Stem Cell Transplant for High Risk Neuroblastoma
-
CLINICAL_TRIALS study record update · 2016-06-2190Y-DOTA-tyr3-Octreotide With or Without Retinoic Acid for the Treatment of Neuroblastoma and Neuroendocrine Tumors in Children and Young Adults. A Randomized, Placebo Controlled Phase II Trial With Dosimetry Guided Dosing
-
CLINICAL_TRIALS study record update · 2016-06-21A Phase I, Open Label, Maximum Tolerated Dose-Finding Study to Evaluate the Safety and Tolerability of 90Y-DOTA-tyr3-Octreotide Administered by Intravenous Infusion to Children With Refractory Somatostatin-Receptor Positive Tumors
-
CLINICAL_TRIALS study record update · 2016-06-20A Phase I Trial for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide
-
CLINICAL_TRIALS study record update · 2016-06-14Phase 2 Study of Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma
-
CLINICAL_TRIALS study record update · 2016-05-19Alternative Lengthening of Telomeres (ALT) in Neuroblastoma